Follow
Zhihui Amy Liu
Zhihui Amy Liu
Princess Margaret Cancer Centre, University Health Network
Verified email at uhnresearch.ca
Title
Cited by
Cited by
Year
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
SV Bratman, SY Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ...
Nature Cancer 1 (9), 873-881, 2020
1662020
Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry
PO Richard, MAS Jewett, S Tanguay, O Saarela, ZA Liu, F Pouliot, ...
BJU international 119 (4), 543-549, 2017
632017
Pathological upstaging of clinical T1 to pathological T3a renal cell carcinoma: a multi-institutional analysis of short-term outcomes
JG Nayak, P Patel, O Saarela, Z Liu, A Kapoor, A Finelli, S Tanguay, ...
Urology 94, 154-160, 2016
602016
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionEVOLVE …
S Lheureux, A Oaknin, S Garg, JP Bruce, A Madariaga, NC Dhani, ...
Clinical Cancer Research 26 (16), 4206-4215, 2020
502020
Implementation and outcomes of virtual care across a tertiary cancer center during COVID-19
A Berlin, M Lovas, T Truong, S Melwani, J Liu, ZA Liu, A Badzynski, ...
JAMA oncology 7 (4), 597-602, 2021
482021
Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort
GA Barayan, F Brimo, LR Bégin, JA Hanley, Z Liu, W Kassouf, ...
BJU international 114 (6b), E99-E104, 2014
482014
The natural history of renal function after surgical management of renal cell carcinoma: results from the Canadian Kidney Cancer Information System
R Mason, A Kapoor, Z Liu, O Saarela, S Tanguay, M Jewett, A Finelli, ...
Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e1-486. e7, 2016
442016
Recovering the raw data behind a non-parametric survival curve
Z Liu, B Rich, JA Hanley
Systematic reviews 3 (1), 1-10, 2014
412014
Curative-intent metastasis-directed therapies for molecularly-defined oligorecurrent prostate cancer: a prospective phase II trial testing the oligometastasis hypothesis
RM Glicksman, U Metser, D Vines, J Valliant, Z Liu, PW Chung, ...
European urology 80 (3), 374-382, 2021
332021
Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer
CM Forbes, RA Rendon, A Finelli, A Kapoor, RB Moore, RH Breau, ...
Urologic Oncology: Seminars and Original Investigations 34 (11), 486. e17 …, 2016
322016
Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative
RK Bansal, S Tanguay, A Finelli, R Rendon, RB Moore, RH Breau, ...
Canadian Urological Association Journal 11 (6), 182, 2017
262017
Quantitative 68Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with 177Lu-DOTATATE
C Ortega, RKS Wong, J Schaefferkoetter, P Veit-Haibach, S Myrehaug, ...
Journal of Nuclear Medicine 62 (10), 1406-1414, 2021
252021
Measuring the mortality impact of breast cancer screening
JA Hanley, M McGregor, Z Liu, EC Strumpf, N Dendukuri
Canadian Journal of Public Health 104 (7), e437-e442, 2013
192013
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, ...
Nature medicine 28 (1), 125-135, 2022
152022
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder
MD Jain, R Lam, Z Liu, RJ Stubbins, A Kahlon, R Kansara, R Goswami, ...
British Journal of Haematology 189 (1), 97-105, 2020
132020
Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium–GCIG Phase II Trial.
S Lheureux, A Oaknin, S Garg, J Bruce, NC Dhani, A Madariaga, L Bonilla, ...
Journal of Clinical Oncology 37 (15_suppl), 5521-5521, 2019
132019
Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort
JG Nayak, P Patel, J Bjazevic, Z Liu, O Saarela, A Kapoor, R Rendon, ...
Canadian Urological Association Journal 9 (11-12), 397, 2015
132015
A multicentered, propensity matched analysis comparing laparoscopic and open surgery for pT3a renal cell carcinoma
P Patel, JG Nayak, Z Liu, O Saarela, M Jewett, R Rendon, A Kapoor, ...
Journal of Endourology 31 (7), 645-650, 2017
122017
Rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in Canada
CA Koch, G Lee, ZA Liu, FF Liu, A Fyles, K Han, A Barry, J Croke, D Rodin, ...
Advances in Radiation Oncology 5 (4), 749-756, 2020
11*2020
A conditional approach to measure mortality reductions due to cancer screening
Z Liu, JA Hanley, O Saarela, N Dendukuri
International Statistical Review 83 (3), 493-510, 2015
112015
The system can't perform the operation now. Try again later.
Articles 1–20